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ABSTRACT 
We are living in a man-made world and often exposed to different chemicals known as 
endocrine disrupting chemicals (EDCs) that negatively influence our hormonal system. These 
compounds have the potential to interrupt a normal steroidogenesis and result in harmful 
effects on the reproductive health of humans and among other organisms. Several studies 
have demonstrated a considerable decrease in fertility biomarkers such as sperm counts, and 
increase in malformations and undermasculinization of the male reproductive tract of 
mammals including humans. Increasing incidence of cryptorchidism, hypospadias and 
micropenis in male babies may be a consequence of the detrimental effect of environmental 
chemicals on male fetuses due to disruption of the steroidogenic machinery in the adrenal 
glands and gonads. The general aim of this thesis was to examine the impact of selected 
EDCs on hormonal function of steroidogenic cells from mice and human. 
In papers 1 and 2 we made use of primary cultures of immature mouse Leydig cells (LCs) to 
probe their response to bisphenol A and mono-phthalates. The cells were incubated with or 
without human chorionic gonadotropin (hCG) and a selection of chemicals ranging in 
concentrations over a certain period of time. It was uncovered that immature mouse LCs with 
varying abilities to produce testosterone were unaffected by estrogenic stimuli. Moreover, 
they exhibited a similar response to mono-phthalates. Our study showed that bisphenol A is 
able to stimulate testosterone production in the hCG pre-treated immature mouse LCs. 
However, among three mono-phthalates, only MEHP significantly increased basal androgen 
production via upregulation of StAR expression. In addition, mono-phthalates disturb a 
normal mitochondrial function, by attenuating ATP generation and increasing super oxide 
synthesis. 
In papers 3 and 4 we had possibility to obtain human abortion material from terminated 
pregnancies at gestational week 9-12. In study 3, we used a primary culture of human 
adrenocortical cells, stimulated with or without adrenocorticotropic hormone (ACTH) with 
resveratrol treatment, whereas in paper 4, the whole tissue of the human fetal adrenal gland 
(HFA) was taken for analysis. We observed that resveratrol had a suppressive effect on the 
synthesis of androstenedione, dehydroepiandrosterone (DHEA) and cortisol by the primary 
culture of human fetal adrenocortical cells through inhibition of lyase activity of cytochrome 
Cyp17 and Cyp21 expression in these cells. With the help of GC-MS/MS expertize was 
detected that the HFA is limited to produce androgens to testosterone and androsterone at the 
first trimester of pregnancy. This finding correlates with an observation of fully activated 
CYP17A1-POR-CYB5 complex and the concurrent upregulation of transcription factors 
(SF1, GATA-6) and downregulation of HSD3B2. 
Altogether, our results indicated that environmental endocrine disruptive chemicals have 
diverse effect on androgen production in steroidogenic cells in rodents and humans. 
Bisphenol A and MEHP should be taken into consideration as possible causes of premature 
maturation in boys. In contrast, pregnant women at an early gestational stage should try to 
avoid taking resveratrol due its ability to suppress steroidogenesis in the human fetal adrenals. 
 
Key words: steroidogenesis, Leydig cells, human fetal adrenals/cells, bishphenol A, MEHP, 
resveratrol  
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1 INTRODUCTION 
Steroidogenesis is a dynamic process to produce steroid hormones from the cholesterol 
derivatives that occur in a variety of tissues, most prominently in the adrenal glands and 
gonads. The normal production of steroids plays a pivotal role to support natural body 
homeostasis and reproductive function. This process is very complex and needs an accurate 
orchestrated performance between single cells and all organs. Biosynthesis of steroids is 
regulated by the hypothalamus-pituitary endocrine axes through the classical negative 
feedback loop where steroid hormones produced by the target endocrine organs (e.g., testes, 
adrenals, ovaries) suppress production of releasing hormones by the hypothalamus, and 
adrenocorticotropins and gonadotropins by the pituitary (Fig.1).   
 
 
 
Figure 1. Schematic illustration of the hypothalamus-pituitary-gonadal and adrenal axes. 
LH, luteinizing hormone; FSH, follicle stimulating hormone. 
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1.1 SEX DIFFERENTIATION  
Gonadal anlagen during the embryonic period can develop into either testes or ovaries. 
Sexual differentiation in the human follows four successive steps:  
1. Formation of the genetic sex occurs when the sperm fertilizes the egg creating an XX 
(female) or XY (male) zygote, dependent on the chromosomal set-up of the sperm.  
2. Sex determination occurs when the yet undifferentiated gonad turns into a testis in XY and 
an ovary in XX embryos. The gonad regulates further development.  
3-4. the development of the internal and the external genitalia is regulated by the gonadal 
hormones. In males this process is dependent of androgens produced by LCs and anti 
Müllerian hormone secreted by Sertoli cells in the testis.  
Every step in this process is important for normal sexual differentiation. 
1.2 THE TESTIS 
The testis is responsible for the sperm production and production and secretion of 
testosterone. 
There are two different compartments in the testes, separated from each other by a basal 
lamina: a tubular and an interstitial one. The tubular compartment where the spermatogenesis 
takes place consists of tubuli seminiferi surrounded by the peritubular cells, and the Sertoli 
and germs cells. The interstitial compartment where the steroidogenesis occurs is composed 
byLCs, macrophages and other immune cells and blood and lymph vessels. 
The function of testis is controlled by the hypothalamus-pituitary-testicular axes (HPG) to the 
same extent as by paracrine and autocrine factors. Gonadotropin releasing hormone (GnRH) 
stimulates the anterior pituitary to release luteinizing hormone (LH) and Follicle stimulating 
hormone (FSH), further these hormones activate androgen production by LCs and convert the 
signal to the germ cells via Sertoli cells, respectively (Morohashi, 1997). 
1.3 LEYDIG CELLS 
Franz Leydig in 1850 first described testicular cells that are situated in the interstitial 
compartment of the testis and their function was unclear until testosterone was first isolated in 
1935.  Leydig cells (LCs) are polygonal cells which contain lipid droplets and a large amount 
of smooth endoplasmic reticulum with the main function to produce testosterone which is 
needed for spermatogenesis and normal male development. There are two types of LCs: fetal 
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Leydig cells (FLC) and adult Leydig cells (ALC) with the same function to generate 
androgens, but with different active period and origin. 
 The fetal Leydig cells   
Fetal Leydig cells (FLC) population start to arise prenatally (around 12.5days of conception 
(dpc) in mice and 14.5dpc in rats, whereas in humans, they are recognized from week 6-7 of 
pregnancy) and produce testosterone which is needed for the normal masculinization of the 
male fetus (Svechnikov et al., 2010b).  
The origin of FLC is still unknown but there are some studies that suggest their development 
from the neural crest (Middendorff et al., 1993;  Mayerhofer et al., 1996), the mesonephros 
(Nishino et al., 2001), adrenal-gonadal primordium (Hatano et al., 1996) or the coelomic 
epithelium (Karl and Capel, 1998). There are many factors that influence the natural 
differentiation of the FLC: genetic background (a normal Y-chromosome containing an intact 
Sry region is essential), some factors produced by Sertoli cells (Dhh and PDGF-A) (Brennan 
et al., 2003;  O'Shaughnessy et al., 2006) and paracrine components. Interestingly, this 
process is LH independent, since fetal testosterone production in a LHR-knock out mice was 
not affected (Pakarinen et al., 2002). 
The number of FLC is significantly higher compare to the ALC (Migrenne et al., 2001), but 
they regress before the birth, although some cells could be found up till 3 month postpartum 
(Ariyaratne and Chamindrani Mendis-Handagama, 2000). 
The adult Leydig cells   
The precursors of ALC are still under discussion. Several studies showed evidence that 
peritubular mesenchymal-like cell types give rise to the progenitors of LCs (Benton et al., 
1995;  Siril Ariyaratne et al., 2000;  Habert et al., 2001), others suggested that vascular 
smooth muscle cells and pericytes undergo trans differentiation into steroidogenic cells 
(Ariyaratne and Chamindrani Mendis-Handagama, 2000). 
One can divide postnatal differentiation of LCs into 3 stages: (1) progenitor stage (in the rat 
testis between day 11-28 and before 3 years of age in humans) LCs are elongated and have 
spindle shape as stem cells, but they have developed mitochondria and lipid droplets and are 
able to produce small amount of androgens; (2) immature stage (from day 28-56 in rats, 
between 3-8 years in humans) LCs are rounder and contain a lot of lipid droplets, express 5α 
reductase II and 3αHSD, which help to convert testosterone to 5α-androstane-3α,17β-diol; (3) 
mature stage (day 56 in rats, in humans at age 9-11 with an end of maturation around 15 years 
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of age) LCs are round and have less lipid droplets and mitochondria, cytoplasm contains large 
amount of smooth endoplasmic reticulum and a well-differentiated Golgi apparatus; they  
produce testosterone as the main steroid and have limited ability to proliferate.  
 
1.4 THE ADRENALS 
1.4.1 The fetal adrenals 
The fetal adrenal gland possesses a remarkable transformation in size, morphology and 
functioning during the fetal and perinatal life. The human primitive adrenal gland can be 
recognized by 3 to 4 weeks of gestation. During the fetal life 3 distinct zones can be 
identified: the fetal zone (FZ) that consists of large eosinophilic cells, and the outer definitive 
zone (DZ), which is comprised of small, densely packed basophilic cells (Hanley et al., 
2001), furthermore with the  help of ultrastructural studies the third zone was distinguished, 
named as the transitional zone (TZ). 
The fetal zone 
The fetal zone (FZ) consists of large (20–50 mm) cells that express steroid acute regulatory 
protein (StAR), CYP11A1, CYP17 and CYP21 and 3βHSD2 and therefore they are able to 
produce dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS), a 
substrate for placental estrogen synthesis, as well as pregnenolone sulphate and 17α- 
hydroxypregnenolone sulphate (Mesiano et al., 1993;  Goto et al., 2006). The FZ works 
similar to the adult zone reticularis.  
The transitional zone  
Cells that lay between the fetal and definitive zone form the transitional zone, where 
CYP11A1, CYP17 and CYP21 and 3βHSD2 genes expression was found. The transitional 
zone may produce glucocorticoids and will give rise to the cortisol-producing zone 
fasciculata (Mesiano et al., 1993;  Goto et al., 2006). 
The definitive zone 
The DZ is composed of a tight group of small (10–20 mm) cells that show structural 
characteristics typical of cells in a proliferative state with poor lipid droplets during the 
midgestation with ability to accumulate cytoplasmic lipid and resemble steroidogenic cells. 
The steroidogenic gene’s profile of this region characterized with the weakly detected 
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expressed   StAR, CYP11A1, CYP21, CYP11B1/CYP11B2 expression and mostly 
undetectable CYP17(Goto et al., 2006). The definitive zone induces formation of the zona 
glomerulosa in the adult adrenal. 
The adrenal cortex increases in weight almost 10-fold from gestation week 8 to 10, and by 
week 20 of gestation reaches the same size as fetal kidney and equal to the adult adrenal 
gland. Nevertheless after the birth, gland undergoes quick involution due a rapid dissipation 
of the FZ and formation of the zonae glomerulosa and fasciculate (Sucheston and Cannon, 
1968). 
1.4.2 The adult adrenals 
The adult human adrenal located on top of the upper pole of kidney and weigh approximately 
4gram. Each gland is divided into two compartments: the medulla (an inner part, responsible 
for the catecholamines, adrenalin and noradrenaline synthesis) and cortex (an outer region), 
which is involved in the steroidogenesis. The adrenal cortex itself is divided to 3 zones: zona 
glomerulosa (where aldosterone is secreted), zona fasciculata (responsible for the cortisol and 
corticosterone production) and zona reticularis (answerable for the androgens synthesis).   
1.4.3 Function and regulation 
The adrenal is under control of the hypothalamus-pituitary-gland axis, where corticotrophin 
releasing hormone (CRH) activates secretion of ACTH in the anterior pituitary, which 
stimulates cells in the adrenal to generate glucocorticoids (Morohashi, 1997).     
The HFA cortex is an active endocrine organ that plays a pivotal role in intrauterine 
equilibrium and the maturation of certain fetal organs, in addition fetal cortisol is involved in 
the triggering parturition. During the first trimester of pregnancy, the HFA is the source of the 
steroid precursors that would be used by placenta to syntheses estrogens. The concept of feto-
placental unit was described first by Diczfalusy (Diczfalusy, 1964) where the placenta, the 
fetal and maternal adrenal glands and the fetal liver work in collaboration in the steroids 
production and metabolism.  
A dysfunction of the adrenal gland leads to the numerous of endocrine diseases. 
Overproduction of cortisol causes Cushing’s syndrome, however deficiency of it is associated 
with Addison’s disease. Genetic mutation in the genes that involved in the glucocorticoid 
production can cause congenital adrenal hyperplasia. 
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1.5 STEROIDOGENESIS  
Steroidogenesis is a biochemical process to produce steroid hormones from cholesterol. 
There are several sources of cholesterol: synthesis of cholesterol from acetate within the cell; 
from cholesterol ester stores that are located in intracellular lipid droplets or from  uptake of 
cholesterol-containing low density lipoproteins. 
Synthesis of steroid hormones required a cascade of oxidative enzymes located in both 
mitochondria and endoplasmic reticulum. The only limitation in this process is the transport 
of free cholesterol from the cytoplasm into mitochondria that happens with the help of 
steroidogenic acute regulatory protein (StAR).  Cholesterol undergoes conversion to 
pregnenolone by an enzyme in the inner membrane of mitochondria, called side-chain 
cleavage enzyme P450scc (CYP11A1). At present, two steroidogenic pathways (Δ5 and Δ 4)  
are described in LCs. The Δ 5 pathway is mostly operative in humans, while Δ4 pathway is 
prevalent in rodents. In these pathways pregnenolone is converted to testosterone via DHEA 
(Δ5 pathway) or progesterone (Δ4 pathway) (Fig.X) 
In human LCs, pregnenolone is converted to17α-Hydroxypregnenolone (17OH5P)  by 
CYP17A1 hydroxylase activity. Further, 17OH-Preg is converted to DHEA by the 17,20 
lyase activity of CYP17A1. This reaction is also supported by oxidoreductase (POR) and 
cytochrome b5 (CYB5). DHEA is then converted to testosterone  through androstenedione 
steroid product of 3β-hydroxysteroid dehydrogenase type II (HSD3B2/3βHSDII) activity. 
Testosterone may be converted to the most potent androgen dihydrotestosterone (DHT). This 
conversion is catalyzed by 5α-reductase type II (SRD5A2 /5αRed2) which is expressed in 
genital skin and the prostate. In rodents, the ∆4 pathway is prevalent in LCs and converts 
pregnenolone to testosterone via progesterone (Fig.2) (Fluck et al., 2003;  Payne and Hales, 
2004). 
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Figure 2. Diagram showing the ∆4 and ∆5 pathways involved in biosynthesis of androgens.  
 
The human adrenal cortex synthesizes mineralocorticoids, glucocorticoids and large amount 
of a weak androgen DHEA. In contrast, rodent adrenals do not express CYP17A1 and have 
no capacity to synthesize DHEA.  The key adrenocortical enzyme involved in the synthesis 
of mineralocorticoids and glucocorticoids is 21-hydroxylase (CYP21A2/P450c21), which 
hydroxylates progesterone (in rodents) and 17-hydroxyprogesterone (in humans) at the 21 
position to deoxycorticosterone and 11-deoxycortisol, respectively. These steroids are further 
converted to corticosterone (in rodents) and cortisol (in humans) by 11β-hydroxylase 
(CYP11B1). Mineralocorticoid aldosterone is synthesized from corticosterone in rodents and 
human by action of aldosterone synthase (CYP11B2) (Fig.3) 
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Figure 3. Overview of steroidogenesis in the adrenal gland. 
 
HFA has their own pattern to synthesize steroid hormones that have features of the ∆ 5, ∆ 4 
and the backdoor pathways to generate androgens with limitation to androsterone and 
testosterone (Savchuk et al., 2017a). Cortisol production by HFA takes place on biphasic 
manner; first it occurs in the early gestational age when the HPA feedback is established and 
then shut down until late of gestation (Goto et al., 2006). 
Recently, it was shown existence of the backdoor pathway (Fig.4), where generation of DHT 
occurs via testosterone independent pathway. According to it, 17OH4P is 5α-reduced to 
17OH-dihydroprogesterone (17OH-DHP) by 5α-reductase type I (SRD5A1/5αRed1) and 
further converted to 17OH-allopregnanolone (17OH-Allo) by the 3α-HSD1-4 (AKR1C1-4) 
enzymes. 17OH-Allo is then sequentially converted to androsterone, androstanediol and 
finally to DHT by actions of CYP17, 17β-hydroxysteroid dehydrogenase, type 3 (HSD17B3) 
and 17β-hydroxysteroid dehydrogenase, type 6 (HSD17B6). This alternative way to produce 
androgens was described in testes of pouch young marsupials (Wilson et al., 2003), in 
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immature mice testes (Mahendroo et al., 2004) and suggested in humans but not proved yet  
(Fluck et al., 2011).  Recent studies have reported the presence of a backdoor pathway of 
DHT synthesis in newborn untreated patients with 21-hydroxylase deficiency (21-OHD), 
suggesting that the HFA could contribute to virilization of the female fetuses with 21-OHD 
via production of this potent androgen (Kamrath et al., 2012).  
 
Figure 4. The “Backdoor pathway” of synthesis of DHT in humans. 
 
1.6 ENDOCRINE DISRUPTING CHEMICALS (EDCS)  
The U.S. Environmental Protection Agency (EPA) specified an endocrine-disrupting 
compound as “an exogenous agent that interferes with synthesis, secretion, transport, 
metabolism, binding action, or elimination of natural blood-borne hormones that are present 
in the body and are responsible for homeostasis, reproduction, and developmental process.” 
Over the past 20 years observations about the harmful impact of environmental chemicals on 
human health and wildlife dramatically increase. Numerous of studies highlighted negative 
influence of endocrine disruptors that can cause adverse effect on the development, 
malformation of the sex organs, cryptorchidism, reproduction, alterations of the puberty,  the 
same as harm the neurological and immune systems, thyroid dysfunction, obesity and 
metabolic disorders, diabetes in both humans and animals (Bergman et al., 2013).  First, it 
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was detected the low sperm concentration in men from industrialized countries in 1990 
(Swan et al., 1997) . Several other studies reported about the increase incidence of testicular 
cancer, declining of sperm quality, impaired development of testes and urogenital 
abnormalities.  These features are characteristics of a testicular dysgenesis syndrome (TDS) 
possibly caused by exogenous factors such as EDC exposure  (Nordkap et al., 2012).  
Several epidemiological studies showed a correlation of negative effect of EDCs on male 
reproductive health in boys (Thankamony et al., 2009;  Bornehag et al., 2012). Elevated risk 
of cryptorchidism among baby-boys was linked to their mothers, who worked as gardeners 
with pesticides (Weidner et al., 1998). Sons, whose fathers were exposed to dioxins (Seveso 
accident in 1997), had increased episodes of hypospadias (Baskin et al., 2001).  
Endocrine disruptors  is highly heterogeneous group of molecules that combines synthetic 
chemicals used as industrial solvents/lubricants and their byproducts (polychlorinated 
biphenyls (PCBs), polybrominated biphenyls (PBBs), dioxins), plastics (bisphenol A (BPA)), 
plasticizers (phthalates), pesticides (methoxychlor, chlorpyrifos, 
dichlorodiphenyltrichloroethane (DDT)), fungicides (vinclozolin), and pharmaceutical agents 
(diethylstilbestrol (DES)), comparable with EDCs that has natural origin, such as  
phytoestrogens, including resveratrol, genistein and coumestrol etc. (Diamanti-Kandarakis et 
al., 2009). 
Exposure to the EDCs happens through different routes: food consumption, water, dust, 
inhalation of gases and particles in the air. These chemicals can be delivered via placenta or 
breast milk from mother to child. EDCs can act via nuclear receptors, non-nuclear steroid 
hormone receptors (membrane ERs), orphan receptors and may affect different steroidogenic 
enzymatic pathways as well as disturb numerous other mechanisms that are important in 
normal functioning of endocrine and reproductive systems. These chemicals often have a 
phenolic compound that can imitate natural steroid hormones and interact with steroid 
hormone receptors as analogs or antagonists. It was reported  that 48% of EDCs have 
estrogenic effect, 19% anti-androgenic, 15% anti-estrogenic, 4% androgenic and 
approximately 42% possess thyroid action (Choi and Lee, 2004). 
There are a lot of evidences that prove negative effect of environmental chemicals on the 
reproductive system (Hardell et al., 2006;  Parent et al., 2015;  Skakkebaek, 2016). Not only 
industrial xenoestrogens even natural examples have a negative impact on the steroidogenesis 
in both adrenocortical and testicular cells (Singleton and Khan, 2003).  
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The compounds examined here 
1.6.1.1. Bisphenol A (BPA) 
 
Figure 5. The chemical structure of bisphenol A (BPA). 
 
Bisphenol A (BPA) is an organic synthetic compound from the group of diphenylmethane 
derivatives and bisphenols, with two hydroxyphenyl groups(Fig.5), first was discovered by 
Russian chemist Aleksandr Dianin and started to be in commercial use since 1957. 
BPA has been used to harden polycarbonate plastics, and make epoxy resin which is 
contained in the lining of food and beverage containers, water and infant bottles, compact 
discs, impact-resistant safety equipment, and medical devices, dental sealants and 
composites. 
People could be exposed to BPA mostly through the diet; other possible sources are air, water 
and dust. It was discovered that 90% of US population has BPA in their urine samples 
(Calafat et al., 2008;  Lakind and Naiman, 2008).It was shown that the levels of BPA in 
maternal plasma could reach 0.3-18.9 ng/ml, while in the fetal plasma the elvel of the 
compound were around 0.2-9.2 and 0.28-0.97 in the breast milk (Schonfelder et al., 2002;  
Sun et al., 2004). 
BPA is a xenoestrogen, exhibiting estrogen-mimicking, hormone-like properties that raise 
concern about its suitability in some consumer products and food containers. It was shown 
that high doses of BPA during pregnancy reduce plasma testosterone at birth in the rat 
(Tanaka et al., 2006) and acting via estrogen receptors (ERs)-dependent 
mechanism(Akingbemi et al., 2004)  suppressed protein expression of the 17beta-
hydroxysteroid dehydrogenase enzyme (HSD17B3), thereby decreasing androgen secretion 
by rat LCs (Nanjappa et al., 2012).   
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1.6.1.2. Phthalates 
 
Figure 6. The chemical formulas of mono-phthalates tested in this thesis.  
 
Phthalates or phthalate esters are esters of phthalic acid and are mainly used to soften and 
increase the flexibility of plastic and vinyl. Phthalates are a group of chemicals that widely 
used in hundreds of consumer products.  
 
One can find phthalates in cosmetics and personal care products, including perfume, hair 
spray, soap, shampoo, nail polish, and skin moisturizers. They are used in products such as 
flexible plastic and vinyl toys, shower curtains, wallpaper, food packaging, and plastic 
wrap. 
Phthalates are also used in wood finishes, detergents, adhesives, plastic plumbing pipes, 
lubricants, medical tubing and fluid bags, solvents, insecticides, medical devices, building 
materials, and vinyl flooring.  
 
High exposure to phthalates, 25mg/kg/day, were detected in group of children who went 
through hemodialysis and blood transfusion (Koch et al., 2006).  
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Several studies reported that European population mostly exposed to the 2 commonly used 
phthalates, di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP) that are 
further metabolized to mono-butyl phthalate (MBP) and mono-2-ethylhexyl phthalate 
(MEHP) (Fig.6), accordingly, and have a negative effect on male reproductive system 
(Wormuth et al., 2006;  Clewell et al., 2010;  Albert and Jegou, 2014). Phthalates have anti-
androgenic effect by attenuation of testosterone production by LCs (Svechnikov et al., 
2010a;  Svechnikov et al., 2015).  
High level of phthalate metabolites in urine samples from pregnant women was found to 
correlate to relatively short ano-genital distance in their male babies (Swan et al., 2005). 
Further,  different types of phthalates have ability to inhibit steroidogenesis by LCs in 
primates and rodents (Koch et al., 2003;  Sharpe, 2005;  Hallmark et al., 2007;  Svechnikov 
et al., 2008). 
 
1.6.1.3. Resveratrol 
 
Figure 7. The chemical structure of resveratrol.  
 
Resveratrol (3, 5, 4’-trihydroxy-trans stilbene) is a stilbenoid, a type of natural phenol, and 
aphytoalexin naturally produced by several plants in response to injury (Fig.7).  
First, it was isolated by Michio Takaoka in 1939 from the plant Veratrum album. In mid-
1990 the”French Paradox” was described, an observation that French people despite having 
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 high fat diet had low rates of cardiovascular diseases. This phenomenon was linked to 
favorable anti-inflammatory and antioxidant effects of resveratrol consumed from red wine 
(Renaud and de Lorgeril, 1992;  Artaud-Wild et al., 1993).   
Resveratrol was found in various plants, including berries and peanuts. This compound exists 
as cis- and trance- isomers but only trance-form has a biological effect: anti-oxidant, anti-
inflammatory, cardioprotective and anti-tumor (Bhat et al., 2001;  Baur et al., 2006;  Park and 
Pezzuto, 2015).  
Resveratrol was reported to have an estrogenic effect, resulting in suppression of expression 
of some steroidogenic enzymes (Supornsilchai et al., 2005;  Oskarsson et al., 2014). It was 
shown that resveratrol and its analogs decrease DHEA, testosterone and cortisol levels 
through inhibition of  CYP17A1 enzyme activity in human adrenocortical carcinoma cells, 
H295R (Oskarsson et al., 2014), moreover it can attenuate steroidogenesis in human fetal 
cells at the end of first trimester (Savchuk et al., 2017b). We found (Svechnikov et al., 2009)  
that resveratrol inhibited hCG-activated steroidogenesis in LCs through suppression of the 
expression of StAR protein and cytochrome P450c17. 
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2 PROJECT AIMS 
 
The general aim of this thesis was to explore mechanisms of action of selected environmental 
endocrine-disrupting chemicals (EDCs) on hormonal function of steroidogenic cells from 
mice and human. 
The specific aims of the projects were: 
1. To explore the relationship between steroidogenic potential of mouse Leydig cells, 
their expression profile of estrogen receptors and responsiveness to estrogenic agonists 
and the xenoestrogen BPA. 
2. To investigate effects of different mono-phthalates on mouse Leydig cell 
steroidogenesis and mitochondrial function and link these effects to steroidogenic 
potential of these cells. 
3. To characterize the  effect of resveratrol on steroid production in human fetal 
adrenocortical cells (HFAC) at the end of the first trimester of pregnancy. 
4. To explore the early onset of steroidogenesis in the human fetal adrenals (HFA) at the 
end of the first trimester of pregnancy. 
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3 METHODOLOGY  
 
3.1 ETHICS 
All studies were performed with permission from an Ethical Board. Animal studies were 
approved by the local animal ethics committee (Stockholm North Animal Ethics Committee 
permits number Dnr N311/12). Human fetal adrenals are collected following elective 
termination of pregnancy. Women give written consent to participate in the project. The 
project is approved by Etikprövningsnämnden (EPN dnr 2014/1022-32). 
3.2 CELL CULTURE  
In papers 1 and 2 Leydig cells were prepared from the testes of immature mice as described 
previously (Svechnikov et al., 2001). Briefly, to obtain purified LCs, a suspension of 
testicular cells was loaded on the top of a discontinuous Percoll gradient and centrifuged. 
Isolated LCs were cultured in 96-well plates with /without stimulation by hCG and treated 
with selected EDCs (BPA and mono-phthalates) in several concentrations for different time 
points. 
In paper 3 HFA (GW9-12) were used to prepare individual primary cultures of HFAC. 
Gestational age was validated by measuring fetal limb length as described previously 
(Evtouchenko et al., 1996). Adrenocortical cells were plated into each well of 96-well 
plates and incubated in the presence or absence of ACTH with or without resveratrol for 
24h.  
 
3.3 HORMONES MEASURMENT   
In papers 1 and 2 culture medium samples were stored at -20ºC prior to analysis of the 
concentrations of testosterone, 17b-estradiol, 5α-androstane-3a, 17b-diol. The 
concentrations of the sex steroids were quantified employing the Coat-a-Count RIA kit 
(Diagnostic Products Corp., Los Angeles, CA, USA). Concentration of 5a-androstane-
3α,17b-diol was also determined by RIA using specific antisera (Cosmo Bio Co. 
LTD.,Tokyo, Japan). 5a-[9, 11-3H (N)] Androstane-3a, 17b-diol (specificity activity, 40 
Ci/mmol) was obtained from NEN Life Science Products (Boston, MA, USA). Serum 
levels of mouse LH were measured by specific ELISA (ABIN415551) from Antibodies 
online (Antibodies-online, Inc, GA, USA) in accordance with manufacturer’s instructions. 
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In papers 3 and 4 the media from HFAC cultures and HFA tissue were stored frozen until 
preparation for analysis. Detection and quantification of androgens and estrogens were 
performed on a Scion 436 gas chromatograph coupled to a Scion TQ triple quadrupole 
mass spectrometer (Bruker, Fremont, CA, USA) as described previously [15, 17]. The LC–
MS/MS analyses of glucocorticoids were carried out using a Dionex Ultimate 3000 
UHPLC with integrated Transcend TLX TurboFlow sample preparation system coupled to 
a TSQ Quantiva triple quadruple mass spectrometer. 
3.4 PROTEIN EXPRESSION 
3.4.1 Wes automated Western blotting and analysis (Papers 2- 4) 
All reagents were prepared and used according to manufacturer’s recommendations for use 
on Wes (ProteinSimple, San Jose, California, www.proteinsimple.com/simon.html). Reagents 
included: biotinylated molecular weight ladder, streptavidin-HRP, fluorescent standards, 
luminol-S, hydrogen peroxide, sample buffer, DTT, stacking matrix, separation matrix, 
running buffer, wash buffer, matrix removal buffer, capillaries, containing a proprietary 
UVactivated chemical linked reagent, and antibody diluent and antibodies (goat-anti rabbit 
secondary antibody). Samples were diluted to adjust protein concentration to 0.8µg in 4µl 
with sample buffer and further diluted 4:1 by adding 1 µl of the 5x master mix. The final 
samples of 5 µl each were boiled 5 min, placed on ice for 5 min, briefly centrifuged and 
applied to proper wells. After plate loading, the separation of proteins by electrophoresis and 
immunodetection took place in the capillary system and were fully automated. Simple 
Western analysis was carried out at room temperature, and instrument default settings were 
used. The digital images were analyzed with Compass software (ProteinSimple) on Wes. 
Band density differences were expressed as percent of control values.  
3.4.2 Immunohistochemistry (Paper 4)   
Paraffin-embedded fetal adrenal tissue was cut to a thickness of 5 μm and mounted on 
microscope slides (P/N10143352, Superfrost Plus, Thermo Scientific, MA, USA) and placed 
at 60°C for 40 min in the oven. Tissue sections were dewaxed with xylene (P/N 02080, 
HistoLab, Gothenburg, Sweden) for 20 minutes and then rehydrated in graded ethanol (99.6, 
96, and 70%). Antigen retrival in 0.01M citrate buffer (pH2 6.0) for 20 minutes, in a water 
bath was used for all slides. Samples were incubated with 3% H2O2 in 96% methanol for 
10 min at RT for non-specific endogenous peroxidase blocking. After washing two times 
for five min each with phosphate-buffered saline (PBS) and one time with phosphate-
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buffered saline (PBS) plus 0.01% Tween20 (P/N P1379, Sigma Aldrich, St.6 Louis, MO), 
the sections were treated with normal 3% goat serum plus 1% bovine serum albumin (BSA) 
in phosphate-buffered saline (PBS) for 60 minutes at RT to avoid non-specific biding. 
Slides were subsequently incubated with primary or unspecific IgGs (for negative control) 
dissolved in 3% goat serum × PBS, overnight at 4°C. After washing step, slides were 
incubated with biotinylated secondary antibody (P/N ab64256, Abcam, Cambridge, MA), 
and then with avidin-biotin-peroxidase complex prepared using Vectastain ABC kit (P/N 
PK-6100, Vector Laboratories, CA, USA) for 60 min at RT. After washing slides were 
stained with DAB (P/N SK-4105, Vector Laboratories, CA, USA) for 20-40 sec at RT, 
washed twice for five min in H2O, counter-stained with Hämalaun solution (1.09249.1000, 
Merck, NJ, USA), rinsed for five min with running tap water, dehydrated with gradually 
increasing concentrations of ethanol, cleared with xylene and mounted with cover glass. 
IgG negative sections exposed to non-immune rabbit and mouse serum in the absence of 
primary antibody were included in all immunohistochemistry runs and showed no positive 
immunostaining. 
3.5 GENE EXPRESSION (PAPERS 1- 4) 
3.5.1 RNA extraction and cDNA producing 
Total RNA was extracted from control and treatment groups by RNeasy Mini Kit 
(74104,Qiagen, Hilden, Germany), according to the protocol provided by the manufacturer. 
The RNA was pretreated with DNAse (RNase-free DNase Set, Qiagen) according to the 
manufacturer’s instructions. The amount of total RNA was measured by photometry 
(BioPhotometer, Hamburg, Germany). The RNA was kept at -80ºC until analysis. Total RNA 
was further processed using iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, 
CA, USA) as proposed in the manufacturer’s protocol. 
3.5.2 Analysis by qPCR  
The samples for qPCR were prepared using iQ SYBR Green Supermix (170-8882, Bio-Rad 
Laboratories, Hercules, California), and the PCR cycles were run at 95ºC for 10 s, 60ºC–
62ºC for 45 s, 95ºC for 60 s, and 55ºC for 60 s followed by a melting curve from 55ºC–
95ºC in steps of 0.5ºC and then held at 4ºC (iCycler iQ, Bio-Rad Laboratories, Hercules, 
California) after having estimated the best reaction conditions by running a temperature 
gradient. All values were normalized to b-actin (papers 1 and 2) or GAPDH (paper 3-4) as a  
housekeeping gene to balance possible irregularities in RNA concentration. To control the 
efficacy of the process, negative control (RT-) was always added to each qPCR assay. 
 20 
Before use all primers were run on a gel to check their validity. The 2∆DDCt method was 
used to calculate the fold changes in gene expression. 
3.6 ATP ASSAY (PAPERS 2- 3) 
Cellular ATP levels in the cells were assessed using the Promega luminescent cell viability 
assay kit (Promega, Fisher Scientific) according to the manufacturer´s protocol. Briefly, 
mouse LCs (Paper 2) or human fetal adrenocortical cells (Paper 3) were incubated with or 
without selected EDC for 24 or 48h and then lysed with Promega Cell Titer-Glo substrate at 
room temperature on an orbital shaker for 2 min, followed by a 10-min standing incubation at 
room temperature enabling cell lysis. Samples were analyzed for overall luminescence using 
a Wallac1420 microplate spectrofluorometer (Perkin Elmer). 
3.7 WST-1 TOXICITY ASSAY AND MEASUREMENT OF EXTRACELLULAR 
SUPEROXIDE PRODUCTION (PAPERS 2- 3) 
Tetrazolium salt WST-1 (Roche, Mannheim, Germany) was used to assay possible toxic 
effects of EDC on steroidogenic cells function. WST-1 is a cell-impermeable compound 
which is reduced to formazan by superoxide generated by specific trans-plasma membrane 
oxidoreductases. Primary cultures of LCs (Paper 2) and HFAC (Paper 3) were incubated with 
or without tested EDC and the media were collected for steroids measurement, and the cells 
underwent incubation in fresh DMEM/F12 phenol-free media with WST-1 for 3 h. The level 
of formazan produced was measured with a filter for 450/10 nm using a Wallac1420 
microplate spectrofluorimeter (Perkin Elmer).  
In paper 2 to prove that WST-1 was reduced into formazan by superoxide, the cells were 
preincubated with superoxide dismutase (SOD) (20 mg/ml), an enzyme that converts 
superoxide into hydrogen peroxide. 
3.8 CELL PROLIFERATION ASSAY (PAPER 2) 
The influence of MEHP on proliferation of immature LCs was assayed by CyQUANT Cell 
Proliferation Assay Kit (C7026, Invitrogen, Ltd, UK) according to the manufacturer’s 
protocol. 
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4 RESULTS AND DISCUSSION 
4.1 EFFECTS OF BISPHENOL A AND MONO-PHTHALATES ON IMMATURE 
MOUSE LEYDIG CELLS ARE NOT CORRELATED TO THEIR ANDROGEN 
PRODUCTIONS POTENTIAL (PAPERS 1-2) 
 Increased incidences of developmental disorders in the male reproductive tract (e.g., 
hypospadias, cryptorchidism, micropenis) as well as testicular cancer and abnormal 
spermatogenesis are thought to be associated with exposure to estrogenic-like endocrine 
disruptors (EDCs) (Skakkebaek et al., 2001). Two of the most widely used xenoestrogens are 
bisphenol A (BPA), exposure to which was found to suppress testicular function via an 
estrogen receptors (ERs)-dependent mechanism in rats (Akingbemi et al., 2004) and phthalic 
acid esters, for  with known toxic effects have been described to take place in the 
reproductive system and LCs (Skakkebaek et al., 2001),and this have been proposed to be 
associated with their anti-androgenic potential. However, there are no reports concerning the 
responsiveness to estrogenic and/or anti-androgenic stimuli from LCs from mice with 
different genetic background. 
In our 1 paper, we used 4 different strains of mice (C57BL/6j, CBA/Lac, 129S2, BALB/c) 
that are commonly used in laboratory investigations. We found that all of them have their 
own pattern for steroidogenesis. There were significant variations in the serum levels of T 
and E2 in different genotypes of mice. CBA/Lac mice had 20-times higher serum level of T, 
but 3-times lower level of E2 compared to C57BL/6j mice (Fig.8). This has been associated 
with lower levels of LH in the serum, suggesting marked differences in LC steroidogenesis in 
these mouse genotypes. The capacity of LCs in C57BL/6j mice to produce the androgen in 
the unstimulated condition and in response to hCG was impaired, while LCs from CBA/Ca 
mice had the highest capacity to produce T.  This is in line with the hypothesis that reduced 
responsiveness to hCG- stimuli by LCs from C57BL/6j mice correlates with the higher levels 
of LH, secreted by the pituitary. The expression of the main steroidogenic genes, such as 
LHR, StAR, 3βHSD1 and Cyp17a1 in LCs from C57BL/6j mice was downregulated 
compared to CBA/Lac mice; whereas Cyp 19 gene expression was upregulated in C57BL/6j 
mice. There is some evidence that proves that the overexpression of Cyp 19 has a negative 
effect on androgen production and fertility in male mice (Li et al., 2001).  
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Figure 8. Strain-related differences in in serum levels of sex hormones in mouse Leydig cells 
The data are expressed as means ± S.E.M (n = 7–15). *P<0.05, **P<0.01, ***P<0.001compared to CBA/Lac; ♣♣P<0.01, 
♣♣♣P<0.001 compared to C57BL/6j 
 
No differences in the expression of estrogen receptors ERα and Gpr30 were found, however 
ERβ expression was much more prominent in LCs from CBA/Lac mice. Interestingly, no 
response to the treatment with estrogenic ERα and ERβ agonist was detected, except after 
treatment with bisphenol A, which significantly increased hCG-activated androgen 
production by LCs from all strains (Fig.9), by suppressing the conversion of testosterone into 
its metabolite 5α-androstane-3α,17β-diol (Fig.10). This finding allowed us to hypothesize that 
LCs with different potential to produce testosterone are resistant to estrogenic stimuli, while 
bisphenol A can influence the steroidogenic function of immature LCs and potentiate the 
induction of early puberty and affect the paracrine environment required for the normal 
development of germ cells.  
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Figure 9. The effect of agonists of estrogen receptors and BPA on basal and hCG-stimulated 
testosterone production by LCs from C57BL/6j and CBA/Lac mice  **P<0.01 compared to 
hCG treatment. 
 
 
Figure 10. BPA suppressed testosterone metabolism by mouse Leydig cells. The data are 
expressed as means ± S.E.M (n = 7–15). *P<0.05, **P<0.01, compared to hCG 
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In contrast, no effects of MEHP, MBP and MBeP on hCG-stimulated T production by LCs 
from both mouse genotypes were found. Among three mono-phthalates tested, MEHP at the 
highest concentration (90µM) had the most prominent potential to stimulate basal T 
production by immature LCs from both CBA and C57BL mice and that was coupled  with a 
significant upregulation of StAR protein expression in these steroidogenic cells. The 
observation that co-treatment of  hCG with mono-phthalates did not lead to higher production 
of testosterone in comparison to stimulation by hCG or MEHP underlines the mechanism that 
preserves the LCs from testosterone overproduction via downregulation of StAR (Houk et al., 
2004).   
The stimulatory effect of MEHP on basal androgen production was associated with an 
increased reduction of  WST-1 to formazan by LCs from both mouse genotypes, suggesting 
an elevated production of extracellular reactive oxygen species (ROS) by the cells that could 
be one of the reasons for StAR upregulation (Zhao et al., 2012). Moreover, our study showed 
that MEHP can suppress mitochondrial function by decreasing ATP production albeit having 
no effect on the proliferative status of these cells. Our study hypothesized that MEHP can 
disturb mitochondrial function and elevate the production of reactive superoxide in LCs that 
may cause oxidative stress in neighborhood cells such as Sertoli and germ cells and induce 
apoptosis.   
Altogether, our data show that C57BL/6j mice have attenuated steroidogenesis. This should 
be taken into consideration when performing experiments that focus on the steroidogenic 
potential of these mice. The main finding of this study is that immature mouse LCs with 
different androgenic potential are resistant to the estrogenic stimuli and this is not associated 
with their responsiveness to mono-phthalates. Xenoestrogen BPA induces hCG-activated 
steroidogenesis via testosterone metabolism suppression. In addition, we showed that among 
the 3 mono-phthalates (MBP, MBeP, MEHP), only MEHP had the potential to stimulate 
basal testosterone production via upregulation of StAR expression and affect normal function 
of mitochondria. Consequently, this can disturb the normal development of germ cells and 
both bisphenol A and MEHP should be taken into consideration when evaluating the different 
reasons of premature maturation of LCs.  
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Figure 11. MEHP activated StAR expression and steroidogenesis in mouse LCs, while BPA 
potentiated hCG-stimulated testosterone production by inhibition its metabolism. 
 
4.2 ANDROGENIC POTENTIAL OF HUMAN FETAL ADRENALS AND THE 
RESPONSE OF HUMAN FETAL ADARENOCORTICAL CELLS TO 
RESVERATROL (PAPERS 3-4) 
The fetal adrenal glands play a decisive role in maintaining the normal homeostasis in the 
uterus during the pregnancy and in the maturation of hormone-dependent organs of the 
developing fetus. Since the capacity of the human adrenal glands (HFA) to produce DHT, the 
most potent androgen, in the first trimester, is poorly investigated, we focused our research on 
the steroidogenic machinery of the HFA and responsiveness of their cells to resveratrol 
stimuli, which is known to suppress steroidogenesis by the adrenals (Supornsilchai et al., 
2005). 
In paper 4, we performed a comprehensive analysis of androgen production by the HFA and 
their cells in vitro and linked them to the expression of steroidogenic enzymes together with 
transcription factors. Our data showed that during the first trimester HFA are able to produce 
steroids of different pathways: ∆5, ∆4, including the backdoor of the DHT synthesis with 
restriction to the production of 17α- OH- dihydroprogesterone, androsterone and 
androstenedione (Fig.12). DHT was not detectable and only its precursors were found such as 
testosterone and androsterone. It is worth mentioning that less than 1% of androstenedione 
was converted to testosterone corroborating a study that demonstrated low levels of 
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testosterone in organ cultures with or without stimulated conditions (Goto et al., 2006). In 
contrast, our experiments demonstrate that the primary cell culture of HFA was not capable 
of producing testosterone. There are two possible explanations for this: the HFA cells lose 
their ability to produce testosterone in culture or the level of testosterone in the media was 
under the threshold of detectability by GC-MS/MS. Nevertheless, we found two forms of 
testosterone in the tissue of HFA, 17α- and 17β- testosterone. This suggests that 
androstenedione could be converted to both forms with the help of 17αHSD, 17βHSD3 and 
17βHSD5 as was reported previously (Goto et al., 2006;  Fluck et al., 2011).  
 
Figure 12. The tissue levels (ng/g) of steroids in the HFA at the end of the first trimester. 
The values shown are means ± SE for five-six HFA tissue samples. **P<0.01, ***P<0.001 
compared to control. ND – not detectable. 
 
We also detected high levels of DHEA and its metabolites that were linked to the low 
expression of 3βHSD2. Interestingly, 3βHSD2 peaked at GW10, but significantly decreased 
at GW11. However the major steroid produced by the HFA was DHEA indicating high 
activity of CYP17A1 and its assistance proteins P450 oxidoreductase (POR) and microsomal 
cytochrome b5 (CYB5A). This was correlated with an elevated expression of SF-1 and 
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GATA-6. The abundance of DHEA and its sulfated derivative serve as precursors for 
placental-derived estradiol, which is critical for sustaining pregnancy (Mesiano and Jaffe, 
1997). Our study indicated that the CYP17A1-POR-CYB5A complex is fully functional in 
the first trimester of pregnancy and, together with transcriptional factors such as SF-1, 
GATA-6 and DAX1, plays a pivotal role in the normal development of the fetal human 
adrenals while maintaining a normal onset of steroidogenesis (Hammer et al., 2005). 
In paper 3, we investigated the influence of the natural polyphenol on steroidogenesis in the 
primary culture of HFAC during the first trimester and demonstrated that this natural 
stilbenoid significantly suppressed the biosynthesis of DHEA, androstenedione and 11-
deoxcortisol by HFAC in stimulated and unstimulated conditions. Furthermore, we found 
that a downregulation of cytochromes 17α-hydroxylase/17, 20 lyase (CYP17) activities and 
expression of 21- hydroxylase (CYP21) in these cells (Fig.12). Hence, we concluded that 
the human fetal adrenals are very sensitive to resveratrol at gestational week 9-12, which is 
a critical period for normal development of the reproductive organ (e.g. gonads, external 
and internal genitalia). The risk of detrimental effects on differentiation should be taken 
into consideration and it is recommended that women who are at early stages of pregnancy 
avoid the intake of resveratrol. 
Using the primary culture of the HFAC in paper 3, we also showed that ACTH upregulated 
steroidogenic enzyme expression and stimulated steroidogenesis in HFACs at GW9-12, 
indicating that ACTHR-coupled signaling pathways involved in the activation of 
steroidogenesis are functional in these steroid-producing cells at the end of the first trimester. 
Along the same line, we found that the expression of MC2R (the ACTHR) is significantly 
increased in the HFA during the last two weeks of the first trimester, suggesting active 
differentiation and maturation of the fetal adrenocortical cells.  
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Figure 12. Resveratrol inhibited expression and activity of Cyp 17 and Cyp21.  
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5 A CRITICAL EVALUATION AND FUTURE 
PERSPECTIVES 
The adverse effects of EDCs on reproductive health should not be neglected. This being said, 
the response to such compounds could depend on the species and the associated 
pharmacokinetics. Rats are known to be more sensitive to the harmful effects of EDCs 
compared to other rodents (Svechnikov et al., 2016). The data about human steroidogenic 
cells are less clear. 
In our first two studies we used a mouse animal model and found a significant effect of 
bisphenol A and MEHP on their steroidogenesis. Future plans would be to define their effect 
in vivo, since all chemicals could be metabolized and their metabolites may induce a 
detrimental impact on fetal and developing gonads and impair their ability to produce 
androgens, since it is known that those chemical compounds could go through the placental 
barrier and reach the fetus. Ultimately, an in vitro model would help in investigating of 
pathways that could be involved in this process and their action on mitochondrial function.     
In studies 3-4, we afforded the chance to work with human abortion material from the first 
trimester of pregnancy and this helped us define the steroidogenic potential of HFA ex vivo 
and investigated androgen production of human fetal adrenocortical cells and their response 
to resveratrol. From a clinical perspective, we suggest that resveratrol, via suppression of the 
activity of certain steroidogenic enzymes (e.g., CYP21), may give rise to a hormonal pattern 
similar to that associated with certain types of autosomal recessive congenital adrenal 
hyperplasia. 
Altogether, one can conclude that the action of EDCs on Leydig and adrenocortical cells 
producing androgens and glucocorticoids is a complex process that depends on the exposure 
route, dose, the developmental stage of the exposed target organism and many other factors. 
Together, these factors determine the potential risk for adverse consequences with long-
lasting effects on male reproductive function, metabolism and stress response. 
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6 MAIN FINDINGS  
• Immature mouse Leydig cells are resistant to estrogenic stimuli independently of 
their capacity to produce testosterone.  
• The xenoestrogen BPA facilitates hCG-induced androgen production by 
immature mouse Leydig cells from both mouse genotypes by attenuating 
conversion of testosterone into its metabolite 3a-Diol. 
• MEHP upregulates StAR expression and stimulates testosterone production by 
developing  mouse LCs independently of their steroidogenic potential. 
• MEHP attenuated ATP production and increased superoxide generation by both 
types of mouse LCs, indicating that mitochondrial dysfunction is affected by the 
mono-phthalate.  
• Resveratrol inhibits synthesis of DHEA, androstenedione and 11-deoxicortisol by 
ACTH-activated and unstimulated HFAC, which was associated with attenuation 
of the activities and expression of CYP17 and CYP21 in these fetal adrenocortical 
cells.  
• The androgenic potential of the HFA at GW9-12 is limited by the production of 
testosterone and androsterone.  
• DHT production by the human fetal adrenocortical cells is limited to its steroid 
precursors such as 17α- OH- dihydroprogesterone, androsterone and 
androstanedion that correlate with expression of steroidogenic genes and their 
transcription factors. 
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